Overall survival in adult patients with low-grade, supratentorial glioma
Ten years’ follow up at a single institution
Keywords:
low-grade glioma, overall survival, disease-free survival, prognostic factors, radiotherapyAbstract
Background: Low-grade gliomas (LGGs) are the second most prevalent type of primary brain tumors in adults. The prognosis for LGGs can differ according to the clinical-pathological prognostic factors determined during diagnosis and treatment. The purpose of this study was to identify 10-year, disease-free survival (DFS), 10-year overall survival (OS), and related clinical-pathological prognostic factors of adult patients with supratentorial, low-grade gliomas who were treated with or without surgery and radiation therapy.
Methods: The study included 110 patients who were confirmed to have low-grade, supratentorial gliomas and who had received surgery and adjuvant radiation therapy or salvage radiotherapy as part of their treatment. These patients were followed by the radiation-oncology ward at Shohada-e-Tajrish Hospital in Tehran, Iran, between 2002 and 2012. The log-rank test (univariate) and the Cox proportional hazards model (multivariate) were used to examine the 10-year DFS and OS and to assess the strengths of various histo-clinical factors relative to 10-year DFS and OS.
Results: The study included 110 patients for whom 10-year DFS and OS were found to be 23 and 28%, respectively. Favorable prognostic factors in the univariate analysis using the Kaplan-Meier 10-year OS analysis were the following: age below 40, karnofsky performance status (KPS) more than 70, the presence of oligodendroglioma, tumor size of < 5 cm, and gross-total resection (p=0.02, p=0.01, p=0.03, p=0.01, p=0.02, respectively). Good prognostic factors in multivariate analysis using the Cox regression model were as follows: age below 40, the presence of oligodendroglioma, tumor size< 5 cm, and gross total resection in10-year OS (p=0.01, p=0.03, p=0.00, p=0.02, respectively).
Conclusions: Gross-total resection, tumor size < 5 cm, age below 40, and the presence of oligodendroglioma had better 10-year DFS and OS rates. We recommend that all patients with LGG tumors be referred to neuro-oncology centers that have sufficient experience to achieve the best results of treatment
References
Central Brain Tumor Registry of the United States. Statistical report: primary brain tumors in the United
States, 1992–1997; Chicago; 2000: 2–31.
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A. The 2007 WHO classification of
tumours of the central nervous system. Acta Neuropathol 2007; 114: 97-109. Doi: 10.1007/s00401-007- 0278-6. PMID: 17618441. PMCID: PMC1929165
Piepmeier J, Christopher S, Spencer D, Byrne T, Kim J, Knisel JP. Variations in the natural history and
survival of patients with supratentorial low-grade astrocytomas. Neurosurgery 1996; 38: 872-8. Doi:
1097/00006123-199605000-00002. PMID: 8727811
Pignatti F, van den Bent M, Curran D, Debruyne C, Sylvester R, Therasse P. et al. Prognostic factors for
survival in adult patients with cerebral low-grade glioma. J Clin Oncol 2002; 20:2076-84. Doi:
1200/JCO.2002.08.121. PMID: 11956268
Leighton C, Fisher B, Bauman G, Depiero S, Stitt L, MacDonald D, et al. Supratentorial low-grade glioma
in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol 1997: 15: 1294-301.
PMID: 9193320
Soffietti R, Chiò A, Giordana MT, Vasario E, Schiffer D. Prognostic factors in well- differentiated cerebral
astrocytomas in the adult. Neurosurgery. 1989; 24: 686-92. Doi: 10.1227/00006123-198905000-00005.
PMID: 2716976
Shaw EG, Scheithauer BW, O'Fallon JR. Supratentorial gliomas: a comparative study by grade and
histologic type.J Neurooncol 1997; 31: 273-8. Doi: 10.1023/A: 1005715703598. PMID: 9049856
Krouwer HG, van Duinen SG, Kamphorst W, van der Valk P, Algra A. Oligoastrocytomas: a
clinicopathological study of 52 cases. J Neurooncol 1997; 33: 223-8. Doi: 10.1023/A: 1005731305078.
PMID: 9195494
Chang EF, Potts MB, Keles GE, Lamborn KR, Chang SM, Barbaro NM, et al. Seizure characteristics and
control following resection in 332 patients with low-grade gliomas. J Neurosurg 2008; 108: 227-35. Doi:
3171/JNS/2008/108/2/0227. PMID: 18240916
Touboul E, Schlienger M. radiation therapy with or with out surgery in the management of low grade brain
astrocytoma a retrospective study of 120 patients, Bull cancer radiotherapy, 1995; 82(4) :388-95. Doi:
1016/0924-4212(96)80055-7. PMID: 8554892
Lang FF, Gilbert MR. Diffusely infiltrative low-grade gliomas in adults. J Clin Oncol 2006; 24: 1236-45.
Doi: 10.1200/JCO.2005.05.2399. PMID: 16525178
Karim AB, Maat B, Hatlevoll R, Menten J, Thomas DG, Mascarenhas F, et al. randomaized trial on doseresponse in radiation therapy of low-grade cerebral glioma: European Organization for Research and
Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 1996; 36: 549-56. Doi:
1016/S0360-3016(96)00352-5. PMID: 8948338
Van den Bent MJ, Afra D, de Witte O, Ben Hassel M, Schraub S, Hoang-Xuan K, et al. Long-term efficacy
of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the
EORTC 22845 randomised trial. Lancet 2005; 366: 985-990. Doi: 10.1016/S0140-6736(05)67070-5. PMID: 16168780
Kaya V, Aksu MG, Korcum AF, Ozdemir B, Ceçen Y, Sindir B, et al. Clinical prognostic factors of
adjuvant radiation therapy for low-grade gliomas: results of 10 years survival. Int J Clin Exp Med. 2014
May 15; 7 (5): 1336-43. eCollection 2014. PMID: 24995092
Bauman G, Fisher B, Watling C, Cairncross JG, Macdonald D. Adult supratentorial low grade glioma; long
term experience at a single institution; 388-95. Int J Radiat Oncol Biol Phys. 2009 Dec 1; 75 (5):1401-7.
Doi: 10.1016/j.ijrobp.2009.01.010. PMID: 19395201
Youland RS, Schomas DA, Brown PD, Nwachukwu C, Buckner JC, Giannini C, et al. Changes in
presentation, treatment, and outcomes of adult low-grade gliomas over the past fifty years. Neuro Oncol
; 15: 1102-10. Doi: 10.1093/neuonc/not080. PMID: 23814262, PMCID: PMC3714159.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
